Drug Profile
406275 - GSK
Alternative Names: 362115; 362115A; 406725; 406725ALatest Information Update: 02 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Analgesics; Antimigraines
- Mechanism of Action Gap junction modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Epilepsy; Migraine; Neuropathic pain
Most Recent Events
- 25 Nov 2004 Phase-I clinical trials in Neuropathic Pain in United Kingdom (unspecified route)
- 16 Jan 2004 Phase-I clinical trials in Epilepsy in United Kingdom (unspecified route)
- 16 Jan 2004 Phase-I clinical trials in Migraine in United Kingdom (unspecified route)